Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Open in API
Filings indexed 1,872 across all filing types
Latest filing 2021-09-29 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
代重要子公司台新藥(股)公司公告受邀參加凱基證券舉辦之 興櫃前線上法人說明會
Regulatory Filings Classification · 95% confidence The document is a short announcement (746 characters) from a listed company (台耀) regarding its important subsidiary (台新藥) being invited to participate in an online investor presentation organized by a securities firm. It includes details about the event date, time, and format, and mentions that the subsidiary will publish the presentation materials later on the public information platform. There is no actual financial data, report content, or detailed analysis included in this document. It is clearly an announcement about an upcoming investor presentation event rather than the presentation itself or a financial report. Therefore, the document fits best into the category of Investor Presentation (IP) announcements or related notices. However, since this document only announces the event and does not contain the presentation materials or detailed financial content, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the event and not the presentation itself. Confidence is high due to clear identification of the document as an announcement of an investor presentation event without substantive financial content.
2021-09-29 Chinese
代重要子公司台新藥(股)公司公告自110年10月7日登錄興櫃 買賣
Regulatory Filings Classification · 95% confidence The document is a short announcement (639 characters) from a listed company (4746 台耀) about an important subsidiary (台新藥股份有限公司) being approved to list on the OTC market starting from 110/10/07 (Taiwan calendar year). It includes details about shareholding and approval from the securities trading center. There is no financial data, no report attached or referenced, and the document is primarily an official regulatory announcement about a subsidiary's trading status. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-09-29 Chinese
公告本公司申請延長國內第四次無擔保轉換公司債乙案之募集 期間業經金管會准予備查
Capital/Financing Update Classification · 95% confidence The document is a short announcement (837 characters) from a company (台耀化學股份有限公司) regarding the extension of the subscription period for its fourth domestic unsecured convertible bonds issuance. It mentions approval from the financial regulatory authority (金管會) and details about the bond issuance and extension period. There is no financial statement, detailed financial analysis, or comprehensive report content. The document is an update on a capital market activity related to financing. Given the content and length, it fits best under Capital/Financing Update (CAP).
2021-09-10 Chinese
110年9月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, share capital sources, and convertible bonds. It does not present a full financial report or analysis but rather a snapshot of capital and share data. The document length is short (809 characters), and it appears to be a regulatory disclosure of capital information rather than a full report or announcement of a report. This fits best with the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2021-09-10 Chinese
110年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It lists their current holdings, pledged shares, and related percentages. The content is focused on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. There is no indication of a report publication, earnings release, or regulatory certification. The document is a disclosure of insider share transactions or holdings, which aligns with the definition of Director's Dealing (DIRS). The document length is about 4619 characters, which is sufficient for a detailed insider shareholding report. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2021-09-09 Chinese
110年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial statements, earnings data, or report announcements. The document is not a general regulatory filing or a report publication announcement but a detailed insider shareholding disclosure. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just a notice or certification.
2021-09-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.